- Trials with a EudraCT protocol (237)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
237 result(s) found for: Percutaneous coronary intervention.
Displaying page 1 of 12.
EudraCT Number: 2005-003013-32 | Sponsor Protocol Number: GE IDE No. A01005 | Start Date*: 2005-11-08 | |||||||||||
Sponsor Name:Deutsches Herzzentrum München | |||||||||||||
Full Title: PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED; MULTICENTER TRIAL OF BIVALIRUDIN AND UN-FRACTIONATED HEPARIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS | |||||||||||||
Medical condition: Coronary Artery Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005446-39 | Sponsor Protocol Number: STH14272 | Start Date*: 2006-04-27 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: Pilot study of a dose-adjusted regimen of tiroban during percutnaeous coronary intervention | ||
Medical condition: Percutaneous coronary intervention for coronary artery stenosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-001285-15 | Sponsor Protocol Number: KOIIM-2019-1 | Start Date*: 2019-06-28 |
Sponsor Name:University Medical Centre Ljubljana | ||
Full Title: Platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention | ||
Medical condition: Comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012206-39 | Sponsor Protocol Number: ALX-0081-2.1/09 | Start Date*: 2009-08-14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Ablynx | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A phase II randomized, open label clinical trial in high risk percutaneous coronary intervention (PCI) patients receiving standard antithrombotic treatment plus either ALX-0081 or GPIIb/IIIa inhibi... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Thrombotic events associated with percutaneous coronary intervention (PCI) in patients with unstable angina or Non ST-Segment Elevation Myocardial Infarction (NSTEMI), or stable angina with at leas... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) CZ (Completed) AT (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000192-14 | Sponsor Protocol Number: TMC-CAN-05-02 | Start Date*: 2006-12-21 | |||||||||||
Sponsor Name:The Medicines Company | |||||||||||||
Full Title: A Clinical Trial Comparing Cangrelor To Clopidogrel In Subjects Who Require Percutaneous Coronary Intervention | |||||||||||||
Medical condition: Subjects with coronary atherosclerosis who require PCI (with or without stent). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) ES (Completed) DE (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003218-36 | Sponsor Protocol Number: 82646 | Start Date*: 2023-06-05 |
Sponsor Name:Radboudumc | ||
Full Title: The safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage | ||
Medical condition: Acute myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002427-32 | Sponsor Protocol Number: TCA-01-III | Start Date*: 2008-07-16 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI FERRARA | |||||||||||||
Full Title: Ajuste del tratamiento con tirofibán en pacientes que presentan resistencia a la aspirina o al clopidogrel: 3T/2R Tailoring Treatment with Tirofiban in patients showing Resistance to aspirin and/o... | |||||||||||||
Medical condition: Pacientes con enfermedad coronaria que van a someterse a una intervención coronaria percutánea. Patients with coronary disease undergoing percutaneous coronary intervention | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003515-58 | Sponsor Protocol Number: ECRI-12-001 | Start Date*: 2013-05-25 | |||||||||||
Sponsor Name:ECRI | |||||||||||||
Full Title: GLOBAL LEADERS: Comparative effectiveness of 1 month of ticagrelor plus aspirin followed by ticagrelor monotherapy versus a current-day intensive dual antiplatelet therapy in all-comers patients un... | |||||||||||||
Medical condition: Subjects either male or female eligible for percutaneous coronary intervention (PCI) with lesions suitable for stent implantation who meet all eligibility criteria and provide written informed cons... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) GB (Completed) AT (Completed) ES (Completed) BE (Completed) NL (Completed) DK (Completed) HU (Completed) PT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003832-24 | Sponsor Protocol Number: GE IDE No. E00605 | Start Date*: 2006-07-10 |
Sponsor Name:Deutsches Herzzentrum München | ||
Full Title: An open, prospective, randomized, comparative study to evaluate the effect of Iodixanol 320 compared to Iomeprol 350 on contrast medium induced nephropathy in patients with impaired renal function ... | ||
Medical condition: Patients with symptomatic coronary artery disease, impaired renal function (GFR<60ml/min) undergoing percutaneous coronary intervention | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010842-67 | Sponsor Protocol Number: ATTICA 01/2009 | Start Date*: 2009-04-16 | ||||||||||||||||
Sponsor Name:OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO | ||||||||||||||||||
Full Title: Effects of periprocedural atorvastatin therapy on patients undergoing percutaneous coronary intervention (PCI) | ||||||||||||||||||
Medical condition: candidates patients for percutaneous coronary intervention revascularization on the basis of claims made by the current guidelines in accordance with the criteria of inclusion / exclusion protocol | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001094-58 | Sponsor Protocol Number: BAY 59-7939 / 15572 | Start Date*: 2011-09-13 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: Prospective, multi-center, randomized, heparin-controlled dose-finding trial to evaluate the efficacy and safety of rivaroxaban, a direct factor Xa inhibitor, on the background of standard dual ant... | |||||||||||||
Medical condition: Symptomatic CAD patients due to undergo an elective (non emergent) Percutaneous Coronary Intervention (PCI) on one or two lesions in the native coronary vessel(s). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021591-28 | Sponsor Protocol Number: TMC-CAN-10-01 | Start Date*: 2011-01-05 | |||||||||||
Sponsor Name:The Medicines Company | |||||||||||||
Full Title: A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention | |||||||||||||
Medical condition: Subjects with coronary atheroschlerosis who require PCI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) CZ (Completed) IT (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004392-23 | Sponsor Protocol Number: T189/2016 | Start Date*: 2018-02-08 |
Sponsor Name:Turku University Hospital | ||
Full Title: 68Ga-NODAGA-RGD cardiac PET in patients with acute myocardial infarction or chronic total coronary occlusion | ||
Medical condition: Acute or chronic coronary artery occlusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000686-32 | Sponsor Protocol Number: Revacept/CAD/02 | Start Date*: 2017-02-10 | |||||||||||
Sponsor Name:German Heart Centre Munich | |||||||||||||
Full Title: Revacept, a novel inhibitor of platelet adhesion in patients with stable coronary artery disease undergoing elective percutaneous coronary interventions: A phase II, multicentre, randomised, dose-... | |||||||||||||
Medical condition: Patients with stable coronary artery disease undergoing elective percutaneous coronary intervention (PCI). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001148-40 | Sponsor Protocol Number: ExcelsiorLOAD | Start Date*: 2014-06-02 | |||||||||||||||||||||
Sponsor Name:Heart Center Freiburg - Bad Krozingen | |||||||||||||||||||||||
Full Title: Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting | |||||||||||||||||||||||
Medical condition: Stable patients with obstructive coronary heart disease undergoing elective percutaneous coronary stent implantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003935-56 | Sponsor Protocol Number: TMC-CAN-05-03 | Start Date*: 2006-11-24 | |||||||||||
Sponsor Name:The Medicines Company | |||||||||||||
Full Title: A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention | |||||||||||||
Medical condition: Subjects with coronary atherosclerosis (excluding ST segment-elevation MI [STEMI]) who require PCI (with or without stent). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) ES (Completed) CZ (Prematurely Ended) LT (Completed) SK (Completed) DE (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002171-29 | Sponsor Protocol Number: GE-IDE-MucT001-14 | Start Date*: 2015-07-16 | ||||||||||||||||
Sponsor Name:Hospital of the University of Munich, Grosshadern | ||||||||||||||||||
Full Title: Intensified Loading with Prasugrel versus Moderate Loading with Clopidogrel in PCI-treated Patients with Biomarker-Negative Angina pectoris. | ||||||||||||||||||
Medical condition: Biomarker-negative patients with an indication for percutaneous coronary intervention | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) HU (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002004-24 | Sponsor Protocol Number: CV185-316 | Start Date*: 2017-02-08 | |||||||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||||||||||||
Full Title: An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillatio... | |||||||||||||||||||||||
Medical condition: Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NO (Completed) BG (Completed) AT (Completed) BE (Completed) DK (Completed) NL (Completed) PL (Completed) PT (Completed) ES (Completed) CZ (Completed) DE (Completed) SE (Completed) SK (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-002304-16 | Sponsor Protocol Number: 130873-2004 | Start Date*: 2005-06-14 |
Sponsor Name:South Tees Hospitals NHS Foundation Trust | ||
Full Title: The STARS (STeroids Against Re-Stenosis) Trial [THE USE OF Peri-PROCEDURAL ORAL CORTICOSTERIODS TO PREVENT IN-SEGMENT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION.] | ||
Medical condition: coronary artery disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005071-25 | Sponsor Protocol Number: ExcelsiorLOAD2 | Start Date*: 2016-01-19 | |||||||||||||||||||||
Sponsor Name:University Heart Center Freiburg - Bad Krozingen | |||||||||||||||||||||||
Full Title: Pharmacodynamic comparison of different oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor in patients undergoing coronary stenting | |||||||||||||||||||||||
Medical condition: Patients with obstructive coronary heart disease undergoing percutaneous coronary stent implantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
